We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$4.21B
AUM Growth
+$306M
Cap. Flow
+$26.3M
Cap. Flow %
0.62%
Top 10 Hldgs %
29.48%
Holding
591
New
35
Increased
212
Reduced
160
Closed
13

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$2.35M
2
TAIL icon
Cambria Tail Risk ETF
TAIL
+$2.23M
3
AAPL icon
Apple
AAPL
+$1.67M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.64M
5
MSFT icon
Microsoft
MSFT
+$1.59M

Sector Composition

Rank Sector Weight
1 Technology 20.06%
2 Healthcare 14.94%
3 Financials 12.73%
4 Communication Services 9.04%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
51
Qualcomm
QCOM
$160B
$22.3M 0.53%
156,020
+3,800
+2% +$514K
UL icon
52
Unilever
UL
$141B
$20.7M 0.49%
313,981
-5,262
-2% -$350K
C icon
53
Citigroup
C
$222B
$20.3M 0.48%
287,574
+3,706
+1% +$274K
SIVB
54
DELISTED
SVB Financial Group
SIVB
$19.2M 0.46%
34,460
-104
-0.3% -$57.7K
IFF icon
55
International Flavors & Fragrances
IFF
$20.3B
$18.7M 0.44%
125,045
+2,442
+2% +$350K
IJR icon
56
iShares Core S&P Small-Cap ETF
IJR
$110B
$18.6M 0.44%
164,258
+1,389
+0.9% +$155K
BDX icon
57
Becton Dickinson
BDX
$45.6B
$18.5M 0.44%
77,770
+8,986
+13% +$2.15M
VWO icon
58
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$17.4M 0.41%
321,165
+3,282
+1% +$175K
CCI icon
59
Crown Castle
CCI
$33.4B
$17.3M 0.41%
88,539
+9,882
+13% +$1.85M
SCHW
60
Charles Schwab
SCHW
$181B
$17.2M 0.41%
235,576
+5,722
+2% +$405K
NTRS icon
61
Northern Trust
NTRS
$22.4B
$17M 0.4%
147,325
-2,048
-1% -$235K
GILD icon
62
Gilead Sciences
GILD
$163B
$16.9M 0.4%
245,643
-20,684
-8% -$1.38M
SHW icon
63
Sherwin-Williams
SHW
$83.7B
$16.8M 0.4%
61,546
-1,961
-3% -$537K
IWR icon
64
iShares Russell Mid-Cap ETF
IWR
$56.1B
$16.6M 0.39%
209,542
-6,065
-3% -$470K
IJH icon
65
iShares Core S&P Mid-Cap ETF
IJH
$122B
$15.8M 0.38%
294,000
-360
-0.1% -$19.4K
PFE icon
66
Pfizer
PFE
$142B
$15.5M 0.37%
396,271
-15,723
-4% -$611K
NOW icon
67
ServiceNow
NOW
$114B
$15.3M 0.36%
139,125
+9,395
+7% +$952K
UNP icon
68
Union Pacific
UNP
$172B
$15.3M 0.36%
69,494
-279
-0.4% -$62.1K
CSCO icon
69
Cisco
CSCO
$448B
$14.6M 0.35%
275,409
+3,021
+1% +$159K
ACN icon
70
Accenture
ACN
$99.9B
$14.6M 0.35%
49,403
-67
-0.1% -$19.2K
CAT icon
71
Caterpillar
CAT
$373B
$13.4M 0.32%
61,646
-231
-0.4% -$53.4K
ATVI
72
DELISTED
Activision Blizzard
ATVI
$13.2M 0.31%
138,214
+3,332
+2% +$316K
KEYS icon
73
Keysight
KEYS
$53.4B
$13.1M 0.31%
85,137
-435
-0.5% -$63.1K
EFA icon
74
iShares MSCI EAFE ETF
EFA
$78.5B
$13.1M 0.31%
166,569
+319
+0.2% +$25.3K
ROBO icon
75
ROBO Global Robotics & Automation Index ETF
ROBO
$1.94B
$13M 0.31%
199,405
+175
+0.1% +$11.2K

Similar funds

Gofen & Glossberg's Q2 2021 Portfolio in Review

As of Q2 2021, Gofen & Glossberg held 591 positions worth $4.21B, up 7.8% from $3.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gofen & Glossberg's Q2 2021 filing shows 35 new, 212 increased, 160 reduced and 13 closed positions. Its largest new stake was Organon & Co: 22,808 shares worth $690K. The largest sale was ASML, an estimated $2.35M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q2 2021 buy was Organon & Co: 22,808 shares worth $690K.
  • Gofen & Glossberg added most to Alcon in Q2 2021, an estimated $7.31M increase.
  • Gofen & Glossberg's biggest Q2 2021 reduction was ASML, cutting an estimated $2.35M.
  • Gofen & Glossberg fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $365K.
  • Gofen & Glossberg's ten largest holdings make up 29% of its $4.21B portfolio in Q2 2021.
  • Gofen & Glossberg opened 35 new positions and closed 13 in Q2 2021.
  • Gofen & Glossberg's portfolio value rose 7.8% quarter-over-quarter to $4.21B.

Based on Gofen & Glossberg's 13F filing for Q2 2021, filed 13 Jul 2021.